全文获取类型
收费全文 | 2525篇 |
免费 | 158篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 158篇 |
妇产科学 | 66篇 |
基础医学 | 341篇 |
口腔科学 | 80篇 |
临床医学 | 234篇 |
内科学 | 395篇 |
皮肤病学 | 46篇 |
神经病学 | 448篇 |
特种医学 | 86篇 |
外科学 | 256篇 |
综合类 | 6篇 |
预防医学 | 270篇 |
眼科学 | 21篇 |
药学 | 79篇 |
中国医学 | 5篇 |
肿瘤学 | 187篇 |
出版年
2024年 | 5篇 |
2023年 | 19篇 |
2022年 | 31篇 |
2021年 | 51篇 |
2020年 | 52篇 |
2019年 | 47篇 |
2018年 | 66篇 |
2017年 | 51篇 |
2016年 | 74篇 |
2015年 | 82篇 |
2014年 | 84篇 |
2013年 | 110篇 |
2012年 | 141篇 |
2011年 | 162篇 |
2010年 | 101篇 |
2009年 | 82篇 |
2008年 | 122篇 |
2007年 | 154篇 |
2006年 | 142篇 |
2005年 | 153篇 |
2004年 | 109篇 |
2003年 | 99篇 |
2002年 | 114篇 |
2001年 | 47篇 |
2000年 | 49篇 |
1999年 | 44篇 |
1998年 | 25篇 |
1997年 | 22篇 |
1996年 | 31篇 |
1995年 | 23篇 |
1994年 | 14篇 |
1993年 | 14篇 |
1992年 | 33篇 |
1991年 | 24篇 |
1990年 | 29篇 |
1989年 | 35篇 |
1988年 | 26篇 |
1987年 | 29篇 |
1986年 | 22篇 |
1985年 | 26篇 |
1984年 | 26篇 |
1983年 | 31篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 5篇 |
1979年 | 16篇 |
1978年 | 7篇 |
1974年 | 5篇 |
1968年 | 5篇 |
1967年 | 6篇 |
排序方式: 共有2694条查询结果,搜索用时 31 毫秒
71.
Vugteveen Jorien de Bildt Annelies Hartman Catharina A. Reijneveld Sijmen A. Timmerman Marieke E. 《European child & adolescent psychiatry》2021,30(12):1983-1994
European Child & Adolescent Psychiatry - The Strengths and Difficulties Questionnaire (SDQ) is widely used, based on evidence of its value for screening. This evidence primarily regards the... 相似文献
72.
Carla Palleis MD Julia Sauerbeck Leonie Beyer MD Stefanie Harris Julia Schmitt Estrella Morenas-Rodriguez PhD Anika Finze Alexander Nitschmann Francois Ruch-Rubinstein Florian Eckenweber Gloria Biechele Tanja Blume MSc Yuan Shi PhD Endy Weidinger MD Catharina Prix MD Kai Bötzel MD Adrian Danek MD Boris-Stephan Rauchmann MD Sophia Stöcklein MD Simon Lindner PhD Marcus Unterrainer MD Nathalie L. Albert MD Christian Wetzel PhD Rainer Rupprecht MD Axel Rominger MD Peter Bartenstein MD Jochen Herms MD Robert Perneczky MD Christian Haass PhD Johannes Levin MD Günter U. Höglinger MD Matthias Brendel MD 《Movement disorders》2021,36(4):883-894
73.
Catharina Müller Oskar Rosmark Emma Åhrman Hans Brunnström Katharina Wassilew Annika Nybom Barbora Michaliková Hillevi Larsson Leif T. Eriksson Hans H. Schultz Michael Perch Johan Malmström Jenny Wigén Martin Iversen Gunilla Westergren-Thorsson 《The American journal of pathology》2021,191(8):1398-1411
74.
75.
76.
Catharina M. L. Zegers Wouter van Elmpt Katrin Szardenings Hartmuth Kolb Alan Waxman Rathan M. Subramaniam Dae Hyuk Moon Jacqueline C. Brunetti Shyam M. Srinivas Philippe Lambin David Chien 《European journal of nuclear medicine and molecular imaging》2015,42(12):1840-1849
Purpose
Hypoxia is an important factor influencing tumor progression and treatment efficacy. The aim of this study was to investigate the repeatability of hypoxia PET imaging with [18F]HX4 in patients with head and neck and lung cancer.Methods
Nine patients with lung cancer and ten with head and neck cancer were included in the analysis (NCT01075399). Two sequential pretreatment [18F]HX4 PET/CT scans were acquired within 1 week. The maximal and mean standardized uptake values (SUVmax and SUVmean) were defined and the tumor-to-background ratios (TBR) were calculated. In addition, hypoxic volumes were determined as the volume of the tumor with a TBR >1.2 (HV1.2). Bland Altman analysis of the uptake parameters was performed and coefficients of repeatability were calculated. To evaluate the spatial repeatability of the uptake, the PET/CT images were registered and a voxel-wise comparison of the uptake was performed, providing a correlation coefficient.Results
All parameters of [18F]HX4 uptake were significantly correlated between scans: SUVmax (r?=?0.958, p?<?0.001), SUVmean (r?=?0.946, p?<?0.001), TBRmax (r?=?0.962, p?<?0.001) and HV1.2 (r?=?0.995, p?<?0.001). The relative coefficients of repeatability were 15 % (SUVmean), 17 % (SUVmax) and 17 % (TBRmax). Voxel-wise analysis of the spatial uptake pattern within the tumors provided an average correlation of 0.65?±?0.14.Conclusion
Repeated hypoxia PET scans with [18F]HX4 provide reproducible and spatially stable results in patients with head and neck cancer and patients with lung cancer. [18F]HX4 PET imaging can be used to assess the hypoxic status of tumors and has the potential to aid hypoxia-targeted treatments.77.
Dessy C Saliez J Ghisdal P Daneau G Lobysheva II Frérart F Belge C Jnaoui K Noirhomme P Feron O Balligand JL 《Circulation》2005,112(8):1198-1205
78.
Severe congenital neutropenia with neurological impairment due to a homozygous VPS45 p.E238K mutation: A case report suggesting a genotype–phenotype correlation
下载免费PDF全文
![点击此处可从《American journal of medical genetics. Part A》网站下载免费的PDF全文](/ch/ext_images/free.gif)
79.
Flora Maria Lorenzo Fortes Ney Boa Sorte Victor D Mariano La la D Andrade Fernanda A Oliveira Monique CA Santos Cl udia Ivanilda N dos Santos Catharina A Passos Mila P Pacheco Valdiana C Surlo Neog lia P de Almeida Jaciane AM Fontes r a M Pimentel Raquel Rocha Genoile Oliveira Santana 《World journal of gastroenterology : WJG》2020,26(44):6993-7004
BACKGROUNDThere has been an increase in cases of inflammatory bowel disease (IBD) in recent years. There is also greater access and availability of immunosuppressive and biological agents, which increase the risk of opportunistic infection despite improving the quality of life and promoting mucosal healing. Tuberculosis (TB) remains a public health problem, and it has a high incidence in several countries. Therefore, knowledge of the risk of developing TB in patients with IBD is important.AIMTo evaluate the risk of active TB in patients with IBD under treatment from an endemic area in Latin America.METHODSA standard questionnaire included demographic variables, clinical aspects of IBD disease, history of active TB during treatment, active TB characteristics and evolution, initial screening and results and time from the start of anti-tumor necrosis factor alpha (TNFα) to TB development.RESULTSAzathioprine, anti-TNFα and the combination of these two drugs were associated with a higher risk of active TB incidence. The TNFα blockers increased the relative risk of developing active TB compared to other treatments. All four multivariable models showed that the use of TNFα blockers alone or in combination with azathioprine was an important risk factor for the incidence of active TB. After adjustment for sex, age, type of IBD and latent TB, anti-TNFα with azathioprine increased the relative risk to 17.8 times more than conventional treatment. Late TB, which was diagnosed 3 mo after the start of anti-TNFα, was the most frequent.CONCLUSIONTreatment with anti-TNFα increased the risk of active TB in IBD patients from an endemic area in Latin America. This risk was increased when anti-TNFα was combined with azathioprine. The time from the beginning of the treatment to the active TB diagnosis suggests a new TB infection. 相似文献
80.